Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects

Clinical trial NCT01374139 · COMPLETED

Trial details

NCT number: NCT01374139
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)

Start date: 2011-08-01
Primary completion: 2011-10-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.